Literature DB >> 8645267

Analysis of heterophilic cell adhesion mediated by CD66b and CD66c using their soluble recombinant proteins.

T Yamanka1, M Kuroki, Y Matsuo, Y Matsuoka.   

Abstract

The heterophilic cell adhesion mediated by CD66b (carcinoembryonic antigen (CEA) gene family member 6, CGM6) and CD66c (nonspecific cross-reacting antigen, NCA), both CEA family members expressed on neutrophils, was investigated using their soluble recombinant proteins prepared in silkworm larvae. The recombinant CD66b and CD66c immobilized on plastic bound CHO transfectants expressing CD66c and CD66b, respectively. Their deglycosylated forms retained the adhesion activity, suggesting that their carbohydrate portions are not prerequisite for the binding. This cell adhesion appeared to be mediated via interaction between the N domains of CD66b and CD66c, because CD66 antibodies recognizing their N domains inhibited the binding. Neutrophils, when activated, adhered to the immobilized CD66b and CD66c. In addition, the binding of primed neutrophils to the antigens induced superoxide anion release. The cell adhesion mediated by CD66b and CD66c may play a role in interaction between neutrophils or between neutrophils and epithelial cells expressing CD66c in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645267     DOI: 10.1006/bbrc.1996.0320

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Interactions of integrins with their partner proteins in leukocyte membranes.

Authors:  Howard R Petty; Randall G Worth; Robert F Todd
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  CD66 receptor specificity exhibited by neisserial Opa variants is controlled by protein determinants in CD66 N-domains.

Authors:  M P Bos; M Kuroki; A Krop-Watorek; D Hogan; R J Belland
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

3.  Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.

Authors:  Rosalyn D Blumenthal; Evelyn Leon; Hans J Hansen; David M Goldenberg
Journal:  BMC Cancer       Date:  2007-01-03       Impact factor: 4.430

4.  CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas.

Authors:  Ok-Jun Lee; Seung-Myoung Son; Kwon Pyo Hong; Yong-Moon Lee; Min-Young Kim; Jae-Woon Choi; Sang-Jeon Lee; Young-Jin Song; Hak Soon Kim; Wun-Jae Kim; See-Ok Shin; Hyung Geun Song
Journal:  Virchows Arch       Date:  2014-11-27       Impact factor: 4.064

5.  Microtube Array Membrane (MTAM)-Based Encapsulated Cell Therapy for Cancer Treatment.

Authors:  Chee Ho Chew; Chih-Wei Lee; Wan-Ting Huang; Li-Wei Cheng; Amanda Chen; Tsai-Mu Cheng; Yen-Lin Liu; Chien-Chung Chen
Journal:  Membranes (Basel)       Date:  2020-04-26

6.  Synthetic peptides from the N-domains of CEACAMs activate neutrophils.

Authors:  K M Skubitz; K D Campbell; A P Skubitz
Journal:  J Pept Res       Date:  2001-12

7.  CEACAM6 promotes cholangiocarcinoma migration and invasion by inducing epithelial-mesenchymal transition through inhibition of the SRC/PI3K/AKT signaling pathway.

Authors:  Chen Liu; Min Wang; Haitao Lv; Bing Liu; Xueqiang Ya; Weihong Zhao; Wenbin Wang
Journal:  Oncol Lett       Date:  2021-12-03       Impact factor: 2.967

8.  Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies.

Authors:  Benny Johnson; Daruka Mahadevan
Journal:  Clin Cancer Drugs       Date:  2015-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.